[NEO]

Mid 2026-07-29 11:21:21

NeoGenomics anticipates $802M-$806M 2026 revenue as it targets mid-20% NGS growth and adjusts pharma expectations

Mid 2026-07-07 23:21:32

Neo Performance Materials offers exposure to the rare-earth magnet supply chain

Mid 2026-07-06 23:35:09

Neogenomics stock hits 52-week high at 15.56 USD